Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium bicarbonate dentifrice refers to experimental toothpaste formulations developed by Church & Dwight Company, Inc., specifically those containing high concentrations (20% and 35%) of sodium bicarbonate (baking soda). These products are designed for the reduction of dental plaque and the treatment of gingivitis. Sodium bicarbonate functions as a mild abrasive that mechanically disrupts the dental plaque biofilm during brushing. Furthermore, it provides a buffering effect that creates an alkaline environment in the oral cavity, which can neutralize plaque acids, inhibit the growth of certain oral pathogens, and potentially reduce gingival inflammation and bleeding. These specific formulations were evaluated in a Phase 2 clinical trial (NCT03214406) to compare their long-term efficacy against a non-sodium bicarbonate control in adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium bicarbonate dentifrice.